Ibacitabine
![]()  | |
| Names | |
|---|---|
| IUPAC name
 2′-Deoxy-5-iodocytidine  | |
| Systematic IUPAC name
 4-Amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2(1H)-one  | |
| Identifiers | |
CAS Number  | 
|
3D model (JSmol)  | 
|
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.009.337 | 
| KEGG | |
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C9H12IN3O4 | 
| Molar mass | 353.11375 | 
| Pharmacology | |
| D06BB08 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Ibacitabine (or ibacitabin,[1] or 5-iodo-2'-deoxycytidine ) is an antiviral drug. It is topically applied to treat herpes labialis.[2]
References
- ↑ Serpentier-Daude, A.; Collet, E.; Didier, A. F.; Touraud, J. P.; Sgro, C.; Lambert, D. (February 2000). "[Contact dermatitis to topical antiviral drugs]". Ann Dermatol Venereol. 127 (2): 191–3. PMID 10739980.
 - ↑ Groot, Anton C. de (2021). Topical drugs (First ed.). Boca Raton, FL: CRC Press. p. 421. ISBN 9781000367867.
 
External links
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
